{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "new",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "04",
                "@timestamp": "2022-01-04T04:59:45.000045-05:00",
                "@year": "2022",
                "@month": "01"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Department of Medicine, Faculty of Medicine, Chulalongkorn University",
                "xocs:funding-id": "001/2565"
            },
            "xocs:funding-addon-generated-timestamp": "2022-01-03T22:59:58.609Z",
            "xocs:funding-text": "Fatty Liver Unit, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (grant number 001/2565).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalong-korn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "113019942"
                                },
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "2015140335-e696d65e3215d927421784a903ed789b",
                            "ce:source-text": "Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalong-korn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand;",
                            "@dptid": "113019942"
                        },
                        "author": [
                            {
                                "ce:given-name": "Thaninee",
                                "preferred-name": {
                                    "ce:given-name": "Thaninee",
                                    "ce:initials": "T.",
                                    "ce:surname": "Prasoppokakorn",
                                    "ce:indexed-name": "Prasoppokakorn T."
                                },
                                "@author-instance-id": "2015140335-054a72e32d86963ace8e6aaa4e5bdb7b",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Prasoppokakorn",
                                "@auid": "57210125771",
                                "ce:indexed-name": "Prasoppokakorn T."
                            },
                            {
                                "ce:given-name": "Sombat",
                                "preferred-name": {
                                    "ce:given-name": "Sombat",
                                    "ce:initials": "S.",
                                    "ce:surname": "Treeprasertsuk",
                                    "ce:indexed-name": "Treeprasertsuk S."
                                },
                                "@author-instance-id": "2015140335-c506bad9b33565283c0ce381d23acf7f",
                                "@seq": "3",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Treeprasertsuk",
                                "@auid": "57077082800",
                                "@orcid": "0000-0001-6459-8329",
                                "ce:indexed-name": "Treeprasertsuk S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of General Internal Medicine"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "100291259"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "2015140335-c5a36a4bcdb57c0c90cfeb62bd92ffea",
                            "ce:source-text": "Division of General Internal Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "100291259"
                        },
                        "author": [{
                            "ce:given-name": "Panyavee",
                            "preferred-name": {
                                "ce:given-name": "Panyavee",
                                "ce:initials": "P.",
                                "ce:surname": "Pitisuttithum",
                                "ce:indexed-name": "Pitisuttithum P."
                            },
                            "@author-instance-id": "2015140335-e5cd759d8e31e045970e7f735c164fea",
                            "@seq": "2",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pitisuttithum",
                            "@auid": "57216309608",
                            "ce:indexed-name": "Pitisuttithum P."
                        }]
                    }
                ],
                "citation-title": "Pharmacological therapeutics: Current trends for metabolic dysfunction-associated fatty liver disease (mafld)",
                "abstracts": "Â© 2021 The Author(s).Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term from nonalcoholic fatty liver disease (NAFLD) and is a positive diagnosis based on histopathology, imaging, or blood biomarkers. MAFLD is one of the common causes of liver dysfunction worldwide, likely due to the increase in metabolic syndrome as well as the high burden of disease and its relationship to other extrahepatic conditions. How-ever, effective pharmacological therapeutic agents are still lacking; current management largely focuses on weight re-duction and lifestyle modification. The purpose of this review was to summarize the updated evidence of novel therapies targeting different pathogenetic pathways in MAFLD.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "1873 Rama 4 Road, Pathumwan district",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Gastroenterology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University and King Chulalongkorn Memorial Hospital"},
                            {"$": "Thai Red Cross Society"}
                        ],
                        "ce:source-text": "* Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873 Rama 4 Road, Pathumwan district, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Sombat",
                        "ce:initials": "S.",
                        "ce:surname": "Treeprasertsuk",
                        "ce:indexed-name": "Treeprasertsuk S."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Metabolic dysfunction-associated fatty liver disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Nonalcoholic fatty liver disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Nonalcoholic steatohepatitis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pharmacological treatment",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "J. Clin. Transl. Hepatol.",
                    "website": {"ce:e-address": {
                        "$": "https://publinestorage.blob.core.windows.net/journals/JCTH.2021.9(6).939.00189.pdf",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": [
                        {
                            "$": "23108819",
                            "@type": "electronic"
                        },
                        {
                            "$": "22250719",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "9",
                            "@issue": "6"
                        },
                        "pagerange": {
                            "@first": "939",
                            "@last": "946"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Xia and He Publishing Inc."},
                    "sourcetitle": "Journal of Clinical and Translational Hepatology",
                    "@srcid": "21101020137",
                    "publicationdate": {
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2021"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2721"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This manuscript was supported in English editing from the research team of the Department of Medicine, Faculty of Medicine, Chulalongkorn University.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-acronym": "CU",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Chulalongkorn University"
                        },
                        "grant-agency-id": "501100002873"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "03",
                    "@timestamp": "BST 10:55:55",
                    "@year": "2022",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015140335",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "937580109",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20220009443",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20220015394",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219020389295",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85121977826",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85121977826",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.14218/JCTH.2021.00189"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "55",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020; 73(1):202\u2013209. doi:10.1016/j.jhep.2020.03.039.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2020.03.039",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85083788691",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "202",
                                    "@last": "209"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Eslam",
                                        "ce:indexed-name": "Eslam M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PN",
                                        "@_fa": "true",
                                        "ce:surname": "Newsome",
                                        "ce:indexed-name": "Newsome PN"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SK",
                                        "@_fa": "true",
                                        "ce:surname": "Sarin",
                                        "ce:indexed-name": "Sarin SK"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "QM",
                                        "@_fa": "true",
                                        "ce:surname": "Anstee",
                                        "ce:indexed-name": "Anstee QM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Targher",
                                        "ce:indexed-name": "Targher G"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Romero-Gomez",
                                        "ce:indexed-name": "Romero-Gomez M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020; 73(1):202\u2013209. doi:10.1016/j.jhep.2020.03.039."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steato-hepatitis: an overview. Hepatol Commun 2020;4(4):478\u2013492. doi:10.1002/ hep4.1479.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Pathogenesis of nonalcoholic steato-hepatitis: an overview"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep4.1479",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85085761605",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "478",
                                    "@last": "492"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Parthasarathy",
                                    "ce:indexed-name": "Parthasarathy G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "X",
                                    "@_fa": "true",
                                    "ce:surname": "Revelo",
                                    "ce:indexed-name": "Revelo X"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Malhi",
                                    "ce:indexed-name": "Malhi H."
                                }
                            ]},
                            "ref-sourcetitle": "Hepatol Commun"
                        },
                        "ce:source-text": "Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steato-hepatitis: an overview. Hepatol Commun 2020;4(4):478\u2013492. doi:10.1002/ hep4.1479."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019;71(4):793\u2013801. doi:10.1016/j.jhep.2019.06.021.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2019.06.021",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85070680426",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "793",
                                    "@last": "801"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ZM",
                                        "@_fa": "true",
                                        "ce:surname": "Younossi",
                                        "ce:indexed-name": "Younossi ZM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Golabi",
                                        "ce:indexed-name": "Golabi P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "de Avila",
                                        "ce:indexed-name": "de Avila L"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Paik",
                                        "ce:indexed-name": "Paik JM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Srishord",
                                        "ce:indexed-name": "Srishord M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Fukui",
                                        "ce:indexed-name": "Fukui N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019;71(4):793\u2013801. doi:10.1016/j.jhep.2019.06.021."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, et al. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. Aliment Pharmacol Ther 2018; 47(6):816\u2013825. doi:10.1111/apt.14506.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/apt.14506",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85040670621",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "816",
                                    "@last": "825"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WK",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan WK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Treeprasertsuk",
                                        "ce:indexed-name": "Treeprasertsuk S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Imajo",
                                        "ce:indexed-name": "Imajo K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Nakajima",
                                        "ce:indexed-name": "Nakajima A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Seki",
                                        "ce:indexed-name": "Seki Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kasama",
                                        "ce:indexed-name": "Kasama K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, et al. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. Aliment Pharmacol Ther 2018; 47(6):816\u2013825. doi:10.1111/apt.14506."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 2016;65(3):589\u2013600. doi:10.1016/j.jhep.2016.05.013.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2016.05.013",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84991083809",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "589",
                                    "@last": "600"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Targher",
                                    "ce:indexed-name": "Targher G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "CD",
                                    "@_fa": "true",
                                    "ce:surname": "Byrne",
                                    "ce:indexed-name": "Byrne CD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Lonardo",
                                    "ce:indexed-name": "Lonardo A"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Zoppini",
                                    "ce:indexed-name": "Zoppini G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Barbui",
                                    "ce:indexed-name": "Barbui C."
                                }
                            ]},
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 2016;65(3):589\u2013600. doi:10.1016/j.jhep.2016.05.013."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328\u2013357. doi:10.1002/hep.29367.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.29367",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85030176004",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "67",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "328",
                                    "@last": "357"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Chalasani",
                                        "ce:indexed-name": "Chalasani N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Younossi",
                                        "ce:indexed-name": "Younossi Z"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Lavine",
                                        "ce:indexed-name": "Lavine JE"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Charlton",
                                        "ce:indexed-name": "Charlton M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Cusi",
                                        "ce:indexed-name": "Cusi K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Rinella",
                                        "ce:indexed-name": "Rinella M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328\u2013357. doi:10.1002/hep.29367."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017;67(4):829\u2013846. doi:10.1016/j.jhep.2017.05.016.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Treatment of NAFLD with diet, physical activity and exercise"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2017.05.016",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85021683483",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "67",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "829",
                                    "@last": "846"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Romero-Gomez",
                                    "ce:indexed-name": "Romero-Gomez M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Zelber-Sagi",
                                    "ce:indexed-name": "Zelber-Sagi S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Trenell",
                                    "ce:indexed-name": "Trenell M."
                                }
                            ]},
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Romero-Gomez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017;67(4):829\u2013846. doi:10.1016/j.jhep.2017.05.016."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminol-ogy. Hepatology 2021;73(3):1194\u20131198. doi:10.1002/hep.31420.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "From NAFLD to MAFLD: implications of a premature change in terminol-ogy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.31420",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85088865440",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "1194",
                                    "@last": "1198"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ZM",
                                        "@_fa": "true",
                                        "ce:surname": "Younossi",
                                        "ce:indexed-name": "Younossi ZM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ME",
                                        "@_fa": "true",
                                        "ce:surname": "Rinella",
                                        "ce:indexed-name": "Rinella ME"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sanyal",
                                        "ce:indexed-name": "Sanyal AJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "EM",
                                        "@_fa": "true",
                                        "ce:surname": "Brunt",
                                        "ce:indexed-name": "Brunt EM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Goodman",
                                        "ce:indexed-name": "Goodman Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminol-ogy. Hepatology 2021;73(3):1194\u20131198. doi:10.1002/hep.31420."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Yilmaz Y, Byrne CD, Musso G. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Rev Gastroenterol Hepatol 2021;15(4):345\u2013352. doi:10.10 80/17474124.2021.1860019.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/17474124.2021.1860019",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85097378307",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "345",
                                    "@last": "352"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Yilmaz",
                                    "ce:indexed-name": "Yilmaz Y"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "CD",
                                    "@_fa": "true",
                                    "ce:surname": "Byrne",
                                    "ce:indexed-name": "Byrne CD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Musso",
                                    "ce:indexed-name": "Musso G."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Yilmaz Y, Byrne CD, Musso G. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. Expert Rev Gastroenterol Hepatol 2021;15(4):345\u2013352. doi:10.10 80/17474124.2021.1860019."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What\u2019s in a name? renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019. Liver Int 2020;40(6):1254\u20131261. doi:10.1111/liv.14478.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "What\u2019s in a name? renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/liv.14478",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85084129499",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1254",
                                    "@last": "1261"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Fouad",
                                    "ce:indexed-name": "Fouad Y"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Waked",
                                    "ce:indexed-name": "Waked I"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Bollipo",
                                    "ce:indexed-name": "Bollipo S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Gomaa",
                                    "ce:indexed-name": "Gomaa A"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Ajlouni",
                                    "ce:indexed-name": "Ajlouni Y"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Attia",
                                    "ce:indexed-name": "Attia D."
                                }
                            ]},
                            "ref-sourcetitle": "Liver Int"
                        },
                        "ce:source-text": "Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What\u2019s in a name? renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019. Liver Int 2020;40(6):1254\u20131261. doi:10.1111/liv.14478."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Brunt EM. What\u2019s in a NAme? Hepatology 2009;50(3):663\u2013667. doi:10.1002/hep.23070.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "What\u2019s in a NAme?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.23070",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "70349246512",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "50",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "663",
                                    "@last": "667"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "EM.",
                                "@_fa": "true",
                                "ce:surname": "Brunt",
                                "ce:indexed-name": "Brunt EM."
                            }]},
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Brunt EM. What\u2019s in a NAme? Hepatology 2009;50(3):663\u2013667. doi:10.1002/hep.23070."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6): 1388\u20131402. doi:10.1016/j.jhep.2015.11.004.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2015.11.004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84962661546",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1388",
                                    "@last": "1402"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)",
                                "ce:indexed-name": "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)"
                            }},
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6): 1388\u20131402. doi:10.1016/j.jhep.2015.11.004."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020;14(6):889\u2013919. doi:10.1007/s12072-020-10094-2.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s12072-020-10094-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85091819550",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "889",
                                    "@last": "919"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Eslam",
                                        "ce:indexed-name": "Eslam M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SK",
                                        "@_fa": "true",
                                        "ce:surname": "Sarin",
                                        "ce:indexed-name": "Sarin SK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "VW",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong VW"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JG",
                                        "@_fa": "true",
                                        "ce:surname": "Fan",
                                        "ce:indexed-name": "Fan JG"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Kawaguchi",
                                        "ce:indexed-name": "Kawaguchi T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn SH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol Int"
                        },
                        "ce:source-text": "Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020;14(6):889\u2013919. doi:10.1007/s12072-020-10094-2."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic stea-tohepatitis. N Engl J Med 2006;355(22):2297\u20132307. doi:10.1056/NEJMoa0 60326.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic stea-tohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa060326",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33751545838",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "355",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "2297",
                                    "@last": "2307"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Belfort",
                                        "ce:indexed-name": "Belfort R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Brown",
                                        "ce:indexed-name": "Brown K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Darland",
                                        "ce:indexed-name": "Darland C"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Finch",
                                        "ce:indexed-name": "Finch J"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Hardies",
                                        "ce:indexed-name": "Hardies J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic stea-tohepatitis. N Engl J Med 2006;355(22):2297\u20132307. doi:10.1056/NEJMoa0 60326."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008;135(4):1176\u2013 1184. doi:10.1053/j.gastro.2008.06.047.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1053/j.gastro.2008.06.047",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "53049101877",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "135",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1176",
                                    "@last": "1184"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "GP",
                                        "@_fa": "true",
                                        "ce:surname": "Aithal",
                                        "ce:indexed-name": "Aithal GP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JA",
                                        "@_fa": "true",
                                        "ce:surname": "Thomas",
                                        "ce:indexed-name": "Thomas JA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PV",
                                        "@_fa": "true",
                                        "ce:surname": "Kaye",
                                        "ce:indexed-name": "Kaye PV"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Lawson",
                                        "ce:indexed-name": "Lawson A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Ryder",
                                        "ce:indexed-name": "Ryder SD"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Spendlove",
                                        "ce:indexed-name": "Spendlove I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008;135(4):1176\u2013 1184. doi:10.1053/j.gastro.2008.06.047."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362(18):1675\u20131685. doi:10.1056/NEJMoa0907929.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa0907929",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "77951874018",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "362",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "1675",
                                    "@last": "1685"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sanyal",
                                        "ce:indexed-name": "Sanyal AJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Chalasani",
                                        "ce:indexed-name": "Chalasani N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KV",
                                        "@_fa": "true",
                                        "ce:surname": "Kowdley",
                                        "ce:indexed-name": "Kowdley KV"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "McCullough",
                                        "ce:indexed-name": "McCullough A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Diehl",
                                        "ce:indexed-name": "Diehl AM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "NM",
                                        "@_fa": "true",
                                        "ce:surname": "Bass",
                                        "ce:indexed-name": "Bass NM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362(18):1675\u20131685. doi:10.1056/NEJMoa0907929."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepa-titis. Am J Gastroenterol 2003;98(11):2485\u20132490. doi:10.1111/j.1572-0241.2003.08699.x.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepa-titis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1572-0241.2003.08699.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0344742265",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "98",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2485",
                                    "@last": "2490"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SA",
                                    "@_fa": "true",
                                    "ce:surname": "Harrison",
                                    "ce:indexed-name": "Harrison SA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Torgerson",
                                    "ce:indexed-name": "Torgerson S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Hayashi",
                                    "ce:indexed-name": "Hayashi P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ward",
                                    "ce:indexed-name": "Ward J"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Schenker",
                                    "ce:indexed-name": "Schenker S."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepa-titis. Am J Gastroenterol 2003;98(11):2485\u20132490. doi:10.1111/j.1572-0241.2003.08699.x."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2006;4(12):1537\u2013 1543. doi:10.1016/j.cgh.2006.09.025.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cgh.2006.09.025",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33845336554",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1537",
                                    "@last": "1543"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Dufour",
                                        "ce:indexed-name": "Dufour JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CM",
                                        "@_fa": "true",
                                        "ce:surname": "Oneta",
                                        "ce:indexed-name": "Oneta CM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JJ",
                                        "@_fa": "true",
                                        "ce:surname": "Gonvers",
                                        "ce:indexed-name": "Gonvers JJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Bihl",
                                        "ce:indexed-name": "Bihl F"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Cerny",
                                        "ce:indexed-name": "Cerny A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Cereda",
                                        "ce:indexed-name": "Cereda JM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2006;4(12):1537\u2013 1543. doi:10.1016/j.cgh.2006.09.025."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Boettcher E, Csako G, Pucino F, Wesley R, Loomba R. Meta-analysis: piogl-itazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2012;35(1):66\u201375. doi:10.1111/j.1365-2036.2011.04912.x.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Meta-analysis: piogl-itazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1365-2036.2011.04912.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "83555164835",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "66",
                                    "@last": "75"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Boettcher",
                                    "ce:indexed-name": "Boettcher E"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Csako",
                                    "ce:indexed-name": "Csako G"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Pucino",
                                    "ce:indexed-name": "Pucino F"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Wesley",
                                    "ce:indexed-name": "Wesley R"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Loomba",
                                    "ce:indexed-name": "Loomba R."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Boettcher E, Csako G, Pucino F, Wesley R, Loomba R. Meta-analysis: piogl-itazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2012;35(1):66\u201375. doi:10.1111/j.1365-2036.2011.04912.x."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Said A, Akhter A. Meta-analysis of randomized controlled trials of pharmaco-logic agents in non-alcoholic steatohepatitis. Ann Hepatol 2017;16(4):538\u2013 547. doi:10.5604/01.3001.0010.0284.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Meta-analysis of randomized controlled trials of pharmaco-logic agents in non-alcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5604/01.3001.0010.0284",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85020689736",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "538",
                                    "@last": "547"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Said",
                                    "ce:indexed-name": "Said A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Akhter",
                                    "ce:indexed-name": "Akhter A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Hepatol"
                        },
                        "ce:source-text": "Said A, Akhter A. Meta-analysis of randomized controlled trials of pharmaco-logic agents in non-alcoholic steatohepatitis. Ann Hepatol 2017;16(4):538\u2013 547. doi:10.5604/01.3001.0010.0284."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ando Y, Jou JH. Nonalcoholic fatty liver disease and recent guideline up-dates. Clin Liver Dis (Hoboken) 2021;17(1):23\u201328. doi:10.1002/cld.1045.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Nonalcoholic fatty liver disease and recent guideline up-dates"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cld.1045",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85100258288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "23",
                                    "@last": "28"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Ando",
                                    "ce:indexed-name": "Ando Y"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JH.",
                                    "@_fa": "true",
                                    "ce:surname": "Jou",
                                    "ce:indexed-name": "Jou JH."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Liver Dis (Hoboken)"
                        },
                        "ce:source-text": "Ando Y, Jou JH. Nonalcoholic fatty liver disease and recent guideline up-dates. Clin Liver Dis (Hoboken) 2021;17(1):23\u201328. doi:10.1002/cld.1045."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "van de Wiel SMW, Bijsmans I, van Mil SWC, van de Graaf SFJ. Identification of FDA-approved drugs targeting the Farnesoid X Receptor. Sci Rep 2019;9(1):2193. doi:10.1038/s41598-019-38668-7.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Identification of FDA-approved drugs targeting the Farnesoid X Receptor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41598-019-38668-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85061700261",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "2193"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SMW",
                                    "@_fa": "true",
                                    "ce:surname": "van de Wiel",
                                    "ce:indexed-name": "van de Wiel SMW"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Bijsmans",
                                    "ce:indexed-name": "Bijsmans I"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SWC",
                                    "@_fa": "true",
                                    "ce:surname": "van Mil",
                                    "ce:indexed-name": "van Mil SWC"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "SFJ.",
                                    "@_fa": "true",
                                    "ce:surname": "van de Graaf",
                                    "ce:indexed-name": "van de Graaf SFJ."
                                }
                            ]},
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "van de Wiel SMW, Bijsmans I, van Mil SWC, van de Graaf SFJ. Identification of FDA-approved drugs targeting the Farnesoid X Receptor. Sci Rep 2019;9(1):2193. doi:10.1038/s41598-019-38668-7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory re-sponse. Hepatology 2008;48(5):1632\u20131643. doi:10.1002/hep.22519.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory re-sponse"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.22519",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "56149085041",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "48",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1632",
                                    "@last": "1643"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "YD",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang YD"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "WD",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen WD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu D"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "BM",
                                    "@_fa": "true",
                                    "ce:surname": "Forman",
                                    "ce:indexed-name": "Forman BM"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang W."
                                }
                            ]},
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory re-sponse. Hepatology 2008;48(5):1632\u20131643. doi:10.1002/hep.22519."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Wagner M, Zollner G, Trauner M. Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflamma-tion. Hepatology 2008;48(5):1383\u20131386. doi:10.1002/hep.22668.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflamma-tion"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.22668",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "56149126257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "48",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1383",
                                    "@last": "1386"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Wagner",
                                    "ce:indexed-name": "Wagner M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Zollner",
                                    "ce:indexed-name": "Zollner G"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Trauner",
                                    "ce:indexed-name": "Trauner M."
                                }
                            ]},
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Wagner M, Zollner G, Trauner M. Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflamma-tion. Hepatology 2008;48(5):1383\u20131386. doi:10.1002/hep.22668."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2015;385(9972):956\u2013965. doi:10.1016/S0140-6736(14)61933-4.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(14)61933-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84929266699",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "385",
                                    "@issue": "9972"
                                },
                                "pagerange": {
                                    "@first": "956",
                                    "@last": "965"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BA",
                                        "@_fa": "true",
                                        "ce:surname": "Neuschwander-Tetri",
                                        "ce:indexed-name": "Neuschwander-Tetri BA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Loomba",
                                        "ce:indexed-name": "Loomba R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sanyal",
                                        "ce:indexed-name": "Sanyal AJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Lavine",
                                        "ce:indexed-name": "Lavine JE"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Van Natta",
                                        "ce:indexed-name": "Van Natta ML"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Abdelmalek",
                                        "ce:indexed-name": "Abdelmalek MF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 2015;385(9972):956\u2013965. doi:10.1016/S0140-6736(14)61933-4."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2019;394(10215):2184\u20132196. doi:10.1016/S0140-6736(19)33041-7.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(19)33041-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85076128877",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "394",
                                    "@issue": "10215"
                                },
                                "pagerange": {
                                    "@first": "2184",
                                    "@last": "2196"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ZM",
                                        "@_fa": "true",
                                        "ce:surname": "Younossi",
                                        "ce:indexed-name": "Younossi ZM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Ratziu",
                                        "ce:indexed-name": "Ratziu V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Loomba",
                                        "ce:indexed-name": "Loomba R"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Rinella",
                                        "ce:indexed-name": "Rinella M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "QM",
                                        "@_fa": "true",
                                        "ce:surname": "Anstee",
                                        "ce:indexed-name": "Anstee QM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Goodman",
                                        "ce:indexed-name": "Goodman Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2019;394(10215):2184\u20132196. doi:10.1016/S0140-6736(19)33041-7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, et al. The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model. Biomedicines 2021;9(1):60. doi:10.3390/biomedicines9010060.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/biomedicines9010060",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85099861960",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "60"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Schwabl",
                                        "ce:indexed-name": "Schwabl P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Hambruch",
                                        "ce:indexed-name": "Hambruch E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Budas",
                                        "ce:indexed-name": "Budas GR"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Supper",
                                        "ce:indexed-name": "Supper P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Burnet",
                                        "ce:indexed-name": "Burnet M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JT",
                                        "@_fa": "true",
                                        "ce:surname": "Liles",
                                        "ce:indexed-name": "Liles JT"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biomedicines"
                        },
                        "ce:source-text": "Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, et al. The non-steroidal FXR agonist cilofexor improves portal hypertension and reduces hepatic fibrosis in a rat NASH model. Biomedicines 2021;9(1):60. doi:10.3390/biomedicines9010060."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Patel K, Harrison SA, Elkhashab M, Trotter JF, Herring R, Rojter SE, et al. Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial. Hepatology 2020;72(1):58\u201371. doi:10.1002/hep.31205.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.31205",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85087881628",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "58",
                                    "@last": "71"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Patel",
                                        "ce:indexed-name": "Patel K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Elkhashab",
                                        "ce:indexed-name": "Elkhashab M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Trotter",
                                        "ce:indexed-name": "Trotter JF"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Herring",
                                        "ce:indexed-name": "Herring R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "SE",
                                        "@_fa": "true",
                                        "ce:surname": "Rojter",
                                        "ce:indexed-name": "Rojter SE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Patel K, Harrison SA, Elkhashab M, Trotter JF, Herring R, Rojter SE, et al. Cilofexor, a nonsteroidal FXR agonist, in patients with noncirrhotic NASH: a phase 2 randomized controlled trial. Hepatology 2020;72(1):58\u201371. doi:10.1002/hep.31205."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lucas KJ, Lopez P, Lawitz E, Sheikh A, Aizenberg D, Hsia S, et al. Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reduc-tions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results. Dig Liver Dis 2020;52(Suppl 1):E38. doi:10.1016/j.dld.2019.12.129.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reduc-tions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.dld.2019.12.129",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85089507956",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {"@first": "E38"}
                            },
                            "ref-text": "(Suppl 1)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KJ",
                                        "@_fa": "true",
                                        "ce:surname": "Lucas",
                                        "ce:indexed-name": "Lucas KJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Lopez",
                                        "ce:indexed-name": "Lopez P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Lawitz",
                                        "ce:indexed-name": "Lawitz E"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Sheikh",
                                        "ce:indexed-name": "Sheikh A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Aizenberg",
                                        "ce:indexed-name": "Aizenberg D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Hsia",
                                        "ce:indexed-name": "Hsia S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Liver Dis"
                        },
                        "ce:source-text": "Lucas KJ, Lopez P, Lawitz E, Sheikh A, Aizenberg D, Hsia S, et al. Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reduc-tions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results. Dig Liver Dis 2020;52(Suppl 1):E38. doi:10.1016/j.dld.2019.12.129."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Pedrosa M, Seyedkazemi S, Francque S, Sanyal A, Rinella M, Charlton M, et al. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: study design of the TANDEM trial. Contemp Clin Trials 2020;88:105889. doi:10.1016/j. cct.2019.105889.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: study design of the TANDEM trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cct.2019.105889",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075281743",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "88"},
                                "pagerange": {"@first": "105889"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Pedrosa",
                                        "ce:indexed-name": "Pedrosa M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Seyedkazemi",
                                        "ce:indexed-name": "Seyedkazemi S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Francque",
                                        "ce:indexed-name": "Francque S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Sanyal",
                                        "ce:indexed-name": "Sanyal A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Rinella",
                                        "ce:indexed-name": "Rinella M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Charlton",
                                        "ce:indexed-name": "Charlton M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Contemp Clin Trials"
                        },
                        "ce:source-text": "Pedrosa M, Seyedkazemi S, Francque S, Sanyal A, Rinella M, Charlton M, et al. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: study design of the TANDEM trial. Contemp Clin Trials 2020;88:105889. doi:10.1016/j. cct.2019.105889."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Grygiel-GÃ³rniak B. Peroxisome proliferator-activated receptors and their li-gands: nutritional and clinical implications\u2014a review. Nutr J 2014;13:17. doi:10.1186/1475-2891-13-17.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Peroxisome proliferator-activated receptors and their li-gands: nutritional and clinical implications\u2014a review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/1475-2891-13-17",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84893794489",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "17"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "ce:surname": "Grygiel-GÃ³rniak",
                                "ce:indexed-name": "Grygiel-Gorniak B."
                            }]},
                            "ref-sourcetitle": "Nutr J"
                        },
                        "ce:source-text": "Grygiel-GÃ³rniak B. Peroxisome proliferator-activated receptors and their li-gands: nutritional and clinical implications\u2014a review. Nutr J 2014;13:17. doi:10.1186/1475-2891-13-17."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome prolif-erator-activated receptor: a family of nuclear receptors role in various dis-eases. J Adv Pharm Technol Res 2011;2(4):236\u2013240. doi:10.4103/2231-4040.90879.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "The peroxisome prolif-erator-activated receptor: a family of nuclear receptors role in various dis-eases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.4103/2231-4040.90879",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84855209400",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "236",
                                    "@last": "240"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Tyagi",
                                    "ce:indexed-name": "Tyagi S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Gupta",
                                    "ce:indexed-name": "Gupta P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AS",
                                    "@_fa": "true",
                                    "ce:surname": "Saini",
                                    "ce:indexed-name": "Saini AS"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Kaushal",
                                    "ce:indexed-name": "Kaushal C"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Sharma",
                                    "ce:indexed-name": "Sharma S."
                                }
                            ]},
                            "ref-sourcetitle": "J Adv Pharm Technol Res"
                        },
                        "ce:source-text": "Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome prolif-erator-activated receptor: a family of nuclear receptors role in various dis-eases. J Adv Pharm Technol Res 2011;2(4):236\u2013240. doi:10.4103/2231-4040.90879."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and-delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology 2016;150(5):1147\u20131159, e1145. doi:10.1053/j.gastro.2016.01.038.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and-delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1053/j.gastro.2016.01.038",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84960140218",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "150",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1147",
                                    "@last": "1159"
                                }
                            },
                            "ref-text": "e1145",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Ratziu",
                                        "ce:indexed-name": "Ratziu V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Francque",
                                        "ce:indexed-name": "Francque S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Bedossa",
                                        "ce:indexed-name": "Bedossa P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Lehert",
                                        "ce:indexed-name": "Lehert P"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Serfaty",
                                        "ce:indexed-name": "Serfaty L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and-delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology 2016;150(5):1147\u20131159, e1145. doi:10.1053/j.gastro.2016.01.038."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Phase 3 study to evaluate the efficacy and safety of elafibranor versus placebo in patients with nonalcoholic steatohepatitis (NASH) (RESOLVE-IT). 2020:NCT02704403.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85121989654",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "NCT02704403",
                            "ref-sourcetitle": "Phase 3 study to evaluate the efficacy and safety of elafibranor versus placebo in patients with nonalcoholic steatohepatitis (NASH) (RESOLVE-IT)"
                        },
                        "ce:source-text": "Phase 3 study to evaluate the efficacy and safety of elafibranor versus placebo in patients with nonalcoholic steatohepatitis (NASH) (RESOLVE-IT). 2020:NCT02704403."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lefere S, Puengel T, Hundertmark J, Penners C, Frank AK, Guillot A, et al. Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages. J Hepatol 2020;73(4):757\u2013770. doi:10.1016/j.jhep.2020.04.025.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2020.04.025",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85086941881",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "757",
                                    "@last": "770"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lefere",
                                        "ce:indexed-name": "Lefere S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Puengel",
                                        "ce:indexed-name": "Puengel T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Hundertmark",
                                        "ce:indexed-name": "Hundertmark J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Penners",
                                        "ce:indexed-name": "Penners C"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "AK",
                                        "@_fa": "true",
                                        "ce:surname": "Frank",
                                        "ce:indexed-name": "Frank AK"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Guillot",
                                        "ce:indexed-name": "Guillot A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Lefere S, Puengel T, Hundertmark J, Penners C, Frank AK, Guillot A, et al. Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages. J Hepatol 2020;73(4):757\u2013770. doi:10.1016/j.jhep.2020.04.025."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sven MF, Pierre B, Manal FA, Quentin MA, Elisabetta B, Vlad R, et al. A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: design of the NATIVE study. Contemp Clin Trials 2020;98:106170. doi:10.1016/j.cct.2020.106170.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: design of the NATIVE study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cct.2020.106170",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85093073352",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "98"},
                                "pagerange": {"@first": "106170"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Sven",
                                        "ce:indexed-name": "Sven MF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Pierre",
                                        "ce:indexed-name": "Pierre B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "FA",
                                        "@_fa": "true",
                                        "ce:surname": "Manal",
                                        "ce:indexed-name": "Manal FA"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Quentin",
                                        "ce:indexed-name": "Quentin MA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Elisabetta",
                                        "ce:indexed-name": "Elisabetta B"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Vlad",
                                        "ce:indexed-name": "Vlad R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Contemp Clin Trials"
                        },
                        "ce:source-text": "Sven MF, Pierre B, Manal FA, Quentin MA, Elisabetta B, Vlad R, et al. A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: design of the NATIVE study. Contemp Clin Trials 2020;98:106170. doi:10.1016/j.cct.2020.106170."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Inventiva announces design of Phase III clinical trial with lanifibranor in NASH. Inventiva 2021, January Available from: https://www.globenews-wire.com/news-release/2021/01/05/2153793/0/en/Inventiva-announces-design-of-Phase-III-clinical-trial-with-lanifibranor-in-NASH.html.",
                        "@id": "37",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.globenews-wire.com/news-release/2021/01/05/2153793/0/en/Inventiva-announces-design-of-Phase-III-clinical-trial-with-lanifibranor-in-NASH.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85111378842",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Inventiva 2021, January",
                            "ref-sourcetitle": "Inventiva announces design of Phase III clinical trial with lanifibranor in NASH"
                        },
                        "ce:source-text": "Inventiva announces design of Phase III clinical trial with lanifibranor in NASH. Inventiva 2021, January Available from: https://www.globenews-wire.com/news-release/2021/01/05/2153793/0/en/Inventiva-announces-design-of-Phase-III-clinical-trial-with-lanifibranor-in-NASH.html."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, et al. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence. Cardiovasc Diabetol 2019;18(1):80. doi:10.1186/s12933-019-0884-3.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12933-019-0884-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85067569284",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "80"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Kaul",
                                        "ce:indexed-name": "Kaul U"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Parmar",
                                        "ce:indexed-name": "Parmar D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Manjunath",
                                        "ce:indexed-name": "Manjunath K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Parmar",
                                        "ce:indexed-name": "Parmar K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "KP",
                                        "@_fa": "true",
                                        "ce:surname": "Patil",
                                        "ce:indexed-name": "Patil KP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cardiovasc Diabetol"
                        },
                        "ce:source-text": "Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, et al. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence. Cardiovasc Diabetol 2019;18(1):80. doi:10.1186/s12933-019-0884-3."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Siddiqui MS, Idowu MO, Parmar D, Borg BB, Denham D, Loo NM, et al. A phase 2 double blinded, randomized controlled trial of saroglitazar in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31509-3. doi:10.1016/j.cgh.2020.10.051.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A phase 2 double blinded, randomized controlled trial of saroglitazar in patients with nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cgh.2020.10.051",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85111945103",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "S1542-3565(20)31509-3",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MS",
                                        "@_fa": "true",
                                        "ce:surname": "Siddiqui",
                                        "ce:indexed-name": "Siddiqui MS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MO",
                                        "@_fa": "true",
                                        "ce:surname": "Idowu",
                                        "ce:indexed-name": "Idowu MO"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Parmar",
                                        "ce:indexed-name": "Parmar D"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "BB",
                                        "@_fa": "true",
                                        "ce:surname": "Borg",
                                        "ce:indexed-name": "Borg BB"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Denham",
                                        "ce:indexed-name": "Denham D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "NM",
                                        "@_fa": "true",
                                        "ce:surname": "Loo",
                                        "ce:indexed-name": "Loo NM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Siddiqui MS, Idowu MO, Parmar D, Borg BB, Denham D, Loo NM, et al. A phase 2 double blinded, randomized controlled trial of saroglitazar in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31509-3. doi:10.1016/j.cgh.2020.10.051."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Gawrieh S, Noureddin M, Loo N, Mohseni R, Awasty V, Cusi K, et al. Saro-glitazar, a PPAR-alpha/gamma agonist, for treatment of nonalcoholic fatty liver disease: a randomized controlled double-blind phase 2 trial. Hepatol-ogy 2021;doi:10.1002/hep.31843.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Saro-glitazar, a PPAR-alpha/gamma agonist, for treatment of nonalcoholic fatty liver disease: a randomized controlled double-blind phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.31843",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85110117314",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Gawrieh",
                                        "ce:indexed-name": "Gawrieh S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Noureddin",
                                        "ce:indexed-name": "Noureddin M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Loo",
                                        "ce:indexed-name": "Loo N"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mohseni",
                                        "ce:indexed-name": "Mohseni R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Awasty",
                                        "ce:indexed-name": "Awasty V"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Cusi",
                                        "ce:indexed-name": "Cusi K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatol-ogy"
                        },
                        "ce:source-text": "Gawrieh S, Noureddin M, Loo N, Mohseni R, Awasty V, Cusi K, et al. Saro-glitazar, a PPAR-alpha/gamma agonist, for treatment of nonalcoholic fatty liver disease: a randomized controlled double-blind phase 2 trial. Hepatol-ogy 2021;doi:10.1002/hep.31843."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Aroda VR. A review of GLP-1 receptor agonists: evolution and advance-ment, through the lens of randomised controlled trials. Diabetes Obes Metab 2018;20(Suppl 1):22\u201333. doi:10.1111/dom.13162.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A review of GLP-1 receptor agonists: evolution and advance-ment, through the lens of randomised controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/dom.13162",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041084528",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "22",
                                    "@last": "33"
                                }
                            },
                            "ref-text": "(Suppl 1)",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "VR.",
                                "@_fa": "true",
                                "ce:surname": "Aroda",
                                "ce:indexed-name": "Aroda VR."
                            }]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Aroda VR. A review of GLP-1 receptor agonists: evolution and advance-ment, through the lens of randomised controlled trials. Diabetes Obes Metab 2018;20(Suppl 1):22\u201333. doi:10.1111/dom.13162."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, et al. Lira-glutide safety and efficacy in patients with non-alcoholic steatohepati-tis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 2016;387(10019):679\u2013690. doi:10.1016/s0140-6736(15)00803-x.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Lira-glutide safety and efficacy in patients with non-alcoholic steatohepati-tis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0140-6736(15)00803-x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84957840942",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "387",
                                    "@issue": "10019"
                                },
                                "pagerange": {
                                    "@first": "679",
                                    "@last": "690"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Armstrong",
                                        "ce:indexed-name": "Armstrong MJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Gaunt",
                                        "ce:indexed-name": "Gaunt P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GP",
                                        "@_fa": "true",
                                        "ce:surname": "Aithal",
                                        "ce:indexed-name": "Aithal GP"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Barton",
                                        "ce:indexed-name": "Barton D"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Hull",
                                        "ce:indexed-name": "Hull D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Parker",
                                        "ce:indexed-name": "Parker R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, et al. Lira-glutide safety and efficacy in patients with non-alcoholic steatohepati-tis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 2016;387(10019):679\u2013690. doi:10.1016/s0140-6736(15)00803-x."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375(4):311\u2013322. doi:10.1056/NEJMoa1603827.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Liraglutide and cardiovascular outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1603827",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84978839381",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "375",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "311",
                                    "@last": "322"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SP",
                                        "@_fa": "true",
                                        "ce:surname": "Marso",
                                        "ce:indexed-name": "Marso SP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GH",
                                        "@_fa": "true",
                                        "ce:surname": "Daniels",
                                        "ce:indexed-name": "Daniels GH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Brown-Frandsen",
                                        "ce:indexed-name": "Brown-Frandsen K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Kristensen",
                                        "ce:indexed-name": "Kristensen P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Mann",
                                        "ce:indexed-name": "Mann JF"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Nauck",
                                        "ce:indexed-name": "Nauck MA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375(4):311\u2013322. doi:10.1056/NEJMoa1603827."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 2021;384(12):1113\u20131124. doi:10.1056/NEJ-Moa2028395.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJ-Moa2028395",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85103394619",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "384",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1113",
                                    "@last": "1124"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PN",
                                        "@_fa": "true",
                                        "ce:surname": "Newsome",
                                        "ce:indexed-name": "Newsome PN"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Buchholtz",
                                        "ce:indexed-name": "Buchholtz K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Cusi",
                                        "ce:indexed-name": "Cusi K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Linder",
                                        "ce:indexed-name": "Linder M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Okanoue",
                                        "ce:indexed-name": "Okanoue T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Ratziu",
                                        "ce:indexed-name": "Ratziu V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 2021;384(12):1113\u20131124. doi:10.1056/NEJ-Moa2028395."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet 2018;392(10160):2180\u20132193. doi:10.1016/s0140-6736(18)32260-8.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0140-6736(18)32260-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85056797659",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "392",
                                    "@issue": "10160"
                                },
                                "pagerange": {
                                    "@first": "2180",
                                    "@last": "2193"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JP",
                                        "@_fa": "true",
                                        "ce:surname": "Frias",
                                        "ce:indexed-name": "Frias JP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Nauck",
                                        "ce:indexed-name": "Nauck MA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Van",
                                        "ce:indexed-name": "Van J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "ME",
                                        "@_fa": "true",
                                        "ce:surname": "Kutner",
                                        "ce:indexed-name": "Kutner ME"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Cui",
                                        "ce:indexed-name": "Cui X"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet 2018;392(10160):2180\u20132193. doi:10.1016/s0140-6736(18)32260-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, et al. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study. Lancet 2018;391(10140):2607\u2013 2618. doi:10.1016/s0140-6736(18)30726-8.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0140-6736(18)30726-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85048885004",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "391",
                                    "@issue": "10140"
                                },
                                "pagerange": {
                                    "@first": "2607",
                                    "@last": "2618"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Ambery",
                                        "ce:indexed-name": "Ambery P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "VE",
                                        "@_fa": "true",
                                        "ce:surname": "Parker",
                                        "ce:indexed-name": "Parker VE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Stumvoll",
                                        "ce:indexed-name": "Stumvoll M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "MG",
                                        "@_fa": "true",
                                        "ce:surname": "Posch",
                                        "ce:indexed-name": "Posch MG"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Heise",
                                        "ce:indexed-name": "Heise T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Plum-Moerschel",
                                        "ce:indexed-name": "Plum-Moerschel L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, et al. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study. Lancet 2018;391(10140):2607\u2013 2618. doi:10.1016/s0140-6736(18)30726-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, et al. Res-metirom (MGL-3196) for the treatment of non-alcoholic steatohepati-tis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 2019;394(10213):2012\u20132024. doi:10.1016/s0140-6736(19)32517-6.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Res-metirom (MGL-3196) for the treatment of non-alcoholic steatohepati-tis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s0140-6736(19)32517-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075510817",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "394",
                                    "@issue": "10213"
                                },
                                "pagerange": {
                                    "@first": "2012",
                                    "@last": "2024"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Bashir",
                                        "ce:indexed-name": "Bashir MR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CD",
                                        "@_fa": "true",
                                        "ce:surname": "Guy",
                                        "ce:indexed-name": "Guy CD"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Moylan",
                                        "ce:indexed-name": "Moylan CA"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JP",
                                        "@_fa": "true",
                                        "ce:surname": "Frias",
                                        "ce:indexed-name": "Frias JP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "The Lancet"
                        },
                        "ce:source-text": "Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, et al. Res-metirom (MGL-3196) for the treatment of non-alcoholic steatohepati-tis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 2019;394(10213):2012\u20132024. doi:10.1016/s0140-6736(19)32517-6."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ratziu V, Sanyal A, Harrison SA, Wong VW, Francque S, Goodman Z, et al. Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study. Hepatology 2020;72(3):892\u2013905. doi:10.1002/hep.31108.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hep.31108",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85082677816",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "892",
                                    "@last": "905"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Ratziu",
                                        "ce:indexed-name": "Ratziu V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Sanyal",
                                        "ce:indexed-name": "Sanyal A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "VW",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong VW"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Francque",
                                        "ce:indexed-name": "Francque S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Goodman",
                                        "ce:indexed-name": "Goodman Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Ratziu V, Sanyal A, Harrison SA, Wong VW, Francque S, Goodman Z, et al. Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study. Hepatology 2020;72(3):892\u2013905. doi:10.1002/hep.31108."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Anstee QM, Neuschwander-Tetri BA, Wong VW, Abdelmalek MF, Younossi ZM, Yuan J, et al. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA phase 3 study design. Contemp Clin Trials 2020;89:105922. doi:10.1016/j.cct.2019.105922.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA phase 3 study design"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cct.2019.105922",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85077060961",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "89"},
                                "pagerange": {"@first": "105922"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "QM",
                                        "@_fa": "true",
                                        "ce:surname": "Anstee",
                                        "ce:indexed-name": "Anstee QM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BA",
                                        "@_fa": "true",
                                        "ce:surname": "Neuschwander-Tetri",
                                        "ce:indexed-name": "Neuschwander-Tetri BA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "VW",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong VW"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Abdelmalek",
                                        "ce:indexed-name": "Abdelmalek MF"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "ZM",
                                        "@_fa": "true",
                                        "ce:surname": "Younossi",
                                        "ce:indexed-name": "Younossi ZM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Yuan",
                                        "ce:indexed-name": "Yuan J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Contemp Clin Trials"
                        },
                        "ce:source-text": "Anstee QM, Neuschwander-Tetri BA, Wong VW, Abdelmalek MF, Younossi ZM, Yuan J, et al. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA phase 3 study design. Contemp Clin Trials 2020;89:105922. doi:10.1016/j.cct.2019.105922."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials. J Hepatol 2020;73(1):26\u201339. doi:10.1016/j.jhep.2020.02.027.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2020.02.027",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85082566789",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "26",
                                    "@last": "39"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "VW",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong VW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Okanoue",
                                        "ce:indexed-name": "Okanoue T"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Bzowej",
                                        "ce:indexed-name": "Bzowej N"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Vuppalanchi",
                                        "ce:indexed-name": "Vuppalanchi R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Younes",
                                        "ce:indexed-name": "Younes Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, et al. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials. J Hepatol 2020;73(1):26\u201339. doi:10.1016/j.jhep.2020.02.027."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, et al. Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterol-ogy 2018;155(4):1140\u20131153. doi:10.1053/j.gastro.2018.07.006.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1053/j.gastro.2018.07.006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85054172940",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "155",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1140",
                                    "@last": "1153"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Abdelmalek",
                                        "ce:indexed-name": "Abdelmalek MF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Caldwell",
                                        "ce:indexed-name": "Caldwell S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Shiffman",
                                        "ce:indexed-name": "Shiffman ML"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Diehl",
                                        "ce:indexed-name": "Diehl AM"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Ghalib",
                                        "ce:indexed-name": "Ghalib R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterol-ogy"
                        },
                        "ce:source-text": "Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, et al. Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterol-ogy 2018;155(4):1140\u20131153. doi:10.1053/j.gastro.2018.07.006."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, et al. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int 2015;35(3):953\u2013966. doi:10.1111/liv.12570.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/liv.12570",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84922708241",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "953",
                                    "@last": "966"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "FJ",
                                        "@_fa": "true",
                                        "ce:surname": "Barreyro",
                                        "ce:indexed-name": "Barreyro FJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Holod",
                                        "ce:indexed-name": "Holod S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PV",
                                        "@_fa": "true",
                                        "ce:surname": "Finocchietto",
                                        "ce:indexed-name": "Finocchietto PV"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Camino",
                                        "ce:indexed-name": "Camino AM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Aquino",
                                        "ce:indexed-name": "Aquino JB"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Avagnina",
                                        "ce:indexed-name": "Avagnina A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Liver Int"
                        },
                        "ce:source-text": "Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, et al. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int 2015;35(3):953\u2013966. doi:10.1111/liv.12570."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Harrison SA, Goodman Z, Jabbar A, Vemulapalli R, Younes ZH, Freilich B, et al. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. J Hepatol 2020;72(5):816\u2013827. doi:10.1016/j. jhep.2019.11.024.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jhep.2019.11.024",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85079288286",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "816",
                                    "@last": "827"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Harrison",
                                        "ce:indexed-name": "Harrison SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Goodman",
                                        "ce:indexed-name": "Goodman Z"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Jabbar",
                                        "ce:indexed-name": "Jabbar A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Vemulapalli",
                                        "ce:indexed-name": "Vemulapalli R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "ZH",
                                        "@_fa": "true",
                                        "ce:surname": "Younes",
                                        "ce:indexed-name": "Younes ZH"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Freilich",
                                        "ce:indexed-name": "Freilich B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Hepatol"
                        },
                        "ce:source-text": "Harrison SA, Goodman Z, Jabbar A, Vemulapalli R, Younes ZH, Freilich B, et al. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. J Hepatol 2020;72(5):816\u2013827. doi:10.1016/j. jhep.2019.11.024."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, et al. Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mecha-nism, and clinical application. Front Pharmacol 2020;11:601. doi:10.3389/fphar.2020.00601.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mecha-nism, and clinical application"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2020.00601",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85086521270",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "601"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Guo",
                                        "ce:indexed-name": "Guo W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang C"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen F"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "HY",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan HY"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, et al. Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mecha-nism, and clinical application. Front Pharmacol 2020;11:601. doi:10.3389/fphar.2020.00601."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zhou J, Chen Y, Yu J, Li T, Lu Z, Chen Y, et al. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: a PRISMA-compliant network meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100(12):e24884. doi:10.1097/MD.0000000000024884.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: a PRISMA-compliant network meta-analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/MD.0000000000024884",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85103479505",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "100",
                                    "@issue": "12"
                                },
                                "pagerange": {"@first": "e24884"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu J"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li T"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu Z"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Medicine (Baltimore)"
                        },
                        "ce:source-text": "Zhou J, Chen Y, Yu J, Li T, Lu Z, Chen Y, et al. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: a PRISMA-compliant network meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100(12):e24884. doi:10.1097/MD.0000000000024884."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85121977826",
        "dc:description": "Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term from nonalcoholic fatty liver disease (NAFLD) and is a positive diagnosis based on histopathology, imaging, or blood biomarkers. MAFLD is one of the common causes of liver dysfunction worldwide, likely due to the increase in metabolic syndrome as well as the high burden of disease and its relationship to other extrahepatic conditions. How-ever, effective pharmacological therapeutic agents are still lacking; current management largely focuses on weight re-duction and lifestyle modification. The purpose of this review was to summarize the updated evidence of novel therapies targeting different pathogenetic pathways in MAFLD.",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85121977826",
        "dc:creator": {"author": [{
            "ce:given-name": "Thaninee",
            "preferred-name": {
                "ce:given-name": "Thaninee",
                "ce:initials": "T.",
                "ce:surname": "Prasoppokakorn",
                "ce:indexed-name": "Prasoppokakorn T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Prasoppokakorn",
            "@auid": "57210125771",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210125771",
            "ce:indexed-name": "Prasoppokakorn T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85121977826"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121977826&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85121977826&origin=inward"
            }
        ],
        "source-id": "21101020137",
        "citedby-count": "7",
        "prism:volume": "9",
        "subtype": "re",
        "dc:title": "Pharmacological therapeutics: Current trends for metabolic dysfunction-associated fatty liver disease (mafld)",
        "openaccess": "1",
        "prism:issn": "23108819 22250719",
        "publishercopyright": "Â© 2021 The Author(s).",
        "prism:issueIdentifier": "6",
        "subtypeDescription": "Review",
        "prism:publicationName": "Journal of Clinical and Translational Hepatology",
        "prism:pageRange": "939-946",
        "prism:endingPage": "946",
        "openaccessFlag": "true",
        "prism:doi": "10.14218/JCTH.2021.00189",
        "prism:startingPage": "939",
        "dc:identifier": "SCOPUS_ID:85121977826",
        "dc:publisher": "Xia and He Publishing Inc."
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Metabolic dysfunction-associated fatty liver disease"
        },
        {
            "@_fa": "true",
            "$": "Nonalcoholic fatty liver disease"
        },
        {
            "@_fa": "true",
            "$": "Nonalcoholic steatohepatitis"
        },
        {
            "@_fa": "true",
            "$": "Pharmacological treatment"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Hepatology",
        "@code": "2721",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Thaninee",
            "preferred-name": {
                "ce:given-name": "Thaninee",
                "ce:initials": "T.",
                "ce:surname": "Prasoppokakorn",
                "ce:indexed-name": "Prasoppokakorn T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Prasoppokakorn",
            "@auid": "57210125771",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210125771",
            "ce:indexed-name": "Prasoppokakorn T."
        },
        {
            "ce:given-name": "Panyavee",
            "preferred-name": {
                "ce:given-name": "Panyavee",
                "ce:initials": "P.",
                "ce:surname": "Pitisuttithum",
                "ce:indexed-name": "Pitisuttithum P."
            },
            "@seq": "2",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Pitisuttithum",
            "@auid": "57216309608",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216309608",
            "ce:indexed-name": "Pitisuttithum P."
        },
        {
            "ce:given-name": "Sombat",
            "preferred-name": {
                "ce:given-name": "Sombat",
                "ce:initials": "S.",
                "ce:surname": "Treeprasertsuk",
                "ce:indexed-name": "Treeprasertsuk S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Treeprasertsuk",
            "@auid": "57077082800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57077082800",
            "ce:indexed-name": "Treeprasertsuk S."
        }
    ]}
}}